Wang Jian, Wang Shaojie, Song Dandan, Zhao Dongmei, Sha Yu, Jiang Yuting, Jing Yongkui, Cheng Maosheng
Key Lab of New Drugs Design and Discovery of Liaoning Province, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Chem Biol Drug Des. 2009 May;73(5):511-4. doi: 10.1111/j.1747-0285.2009.00807.x. Epub 2009 Mar 23.
Resistance to chemotherapeutic drugs has long been a considerable barrier to successful treatment of many cancers and over-expression of glutathione S-transferase P1-1 is correlated to carcinogenesis and resistance of cancer cells against chemotherapeutic agents. This study throws light on the role of chalcone derivatives, a new class of glutathione S-transferase P1-1 inhibitors potentially to overcome glutathione S-transferase P1-1-mediated chemotherapy resistance. Nineteen alpha-substituted chalcone derivatives were synthesized and their in vitro inhibitory effects on glutathione S-transferase P1-1 were determined. We interestingly found that most of these compounds showed inhibitory effect on glutathione S-transferase P1-1 activity. In addition, molecular field-based similarity analysis provides the necessary three-dimensional molecular field properties of alpha, beta-unsaturated carbonyl derivatives to inhibit glutathione S-transferase P1-1 activity. Thus, these compounds have great potential to be developed into novel chemotherapeutic sensitizers.
对化疗药物的耐药性长期以来一直是成功治疗多种癌症的重大障碍,而谷胱甘肽S-转移酶P1-1的过度表达与癌症发生及癌细胞对化疗药物的耐药性相关。本研究揭示了查尔酮衍生物的作用,这是一类新型的谷胱甘肽S-转移酶P1-1抑制剂,有可能克服谷胱甘肽S-转移酶P1-1介导的化疗耐药性。合成了19种α-取代查尔酮衍生物,并测定了它们对谷胱甘肽S-转移酶P1-1的体外抑制作用。我们有趣地发现,这些化合物中的大多数对谷胱甘肽S-转移酶P1-1活性表现出抑制作用。此外,基于分子场的相似性分析提供了α,β-不饱和羰基衍生物抑制谷胱甘肽S-转移酶P1-1活性所需的三维分子场性质。因此,这些化合物具有很大的潜力被开发成新型化疗增敏剂。